CNNM3

gene
On this page

Also known as SLC70A3

Summary

CNNM3 (cyclin and CBS domain divalent metal cation transport mediator 3, HGNC:104) is a protein-coding gene on chromosome 2q11.2, encoding Metal transporter CNNM3 (Q8NE01). Probable metal transporter.

Predicted to enable transmembrane transporter activity. Predicted to be involved in magnesium ion homeostasis. Located in membrane.

Source: NCBI Gene 26505 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 153 total
  • MANE Select transcript: NM_017623

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:104
Approved symbolCNNM3
Namecyclin and CBS domain divalent metal cation transport mediator 3
Location2q11.2
Locus typegene with protein product
StatusApproved
AliasesSLC70A3
Ensembl geneENSG00000168763
Ensembl biotypeprotein_coding
OMIM607804
Entrez26505

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 7 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000305510, ENST00000377060, ENST00000465224, ENST00000480035, ENST00000494595, ENST00000867797, ENST00000947262, ENST00000947263, ENST00000947264, ENST00000947265

RefSeq mRNA: 2 — MANE Select: NM_017623 NM_017623, NM_199078

CCDS: CCDS2025, CCDS2026

Canonical transcript exons

ENST00000305510 — 8 exons

ExonStartEnd
ENSE000011608959682856796828700
ENSE000011609029682809996828195
ENSE000011609099682773196827900
ENSE000011609209682505896825201
ENSE000018533379681626896817502
ENSE000035208969682899696829134
ENSE000035305709682683396826982
ENSE000038441059683255296835382

Expression profiles

Bgee: expression breadth ubiquitous, 250 present calls, max score 95.34.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0165 / max 63.2175, expressed in 1683 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
214907.64821680
214920.3683215

Top tissues by expression

285 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
gastrocnemiusUBERON:000138895.34gold quality
muscle of legUBERON:000138394.68gold quality
cerebellar hemisphereUBERON:000224594.39gold quality
right hemisphere of cerebellumUBERON:001489094.39gold quality
cerebellar cortexUBERON:000212994.26gold quality
right uterine tubeUBERON:000130294.19gold quality
hindlimb stylopod muscleUBERON:000425294.18gold quality
cerebellumUBERON:000203793.44gold quality
ventricular zoneUBERON:000305392.82gold quality
cardia of stomachUBERON:000116291.16gold quality
pylorusUBERON:000116691.12gold quality
body of pancreasUBERON:000115091.10gold quality
sural nerveUBERON:001548890.55gold quality
left ovaryUBERON:000211990.22gold quality
body of uterusUBERON:000985390.16gold quality
tibial nerveUBERON:000132390.11gold quality
nippleUBERON:000203089.93gold quality
right lobe of liverUBERON:000111489.92gold quality
right ovaryUBERON:000211889.72gold quality
fundus of stomachUBERON:000116089.62gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099189.50gold quality
pancreasUBERON:000126488.97gold quality
ganglionic eminenceUBERON:000402388.88gold quality
mucosa of stomachUBERON:000119988.84gold quality
islet of LangerhansUBERON:000000688.83gold quality
muscle layer of sigmoid colonUBERON:003580588.80gold quality
pituitary glandUBERON:000000788.68gold quality
endocervixUBERON:000045888.62gold quality
cortical plateUBERON:000534388.53gold quality
body of stomachUBERON:000116188.30gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-5061yes240.85
E-ANND-3yes8.78
E-MTAB-6142no36.50

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

150 targeting CNNM3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-518D-5P100.0067.51979
HSA-MIR-518E-5P100.0067.66954
HSA-MIR-518F-5P100.0067.51979
HSA-MIR-519A-5P100.0067.66954
HSA-MIR-519B-5P100.0067.66954
HSA-MIR-519C-5P100.0067.66954
HSA-MIR-520C-5P100.0067.51979
HSA-MIR-522-5P100.0067.66954
HSA-MIR-523-5P100.0067.66954
HSA-MIR-526A-5P100.0067.51979
HSA-MIR-4673100.0066.641490
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-6798-5P100.0065.77699
HSA-MIR-4455100.0065.481587
HSA-MIR-3667-3P99.9967.171636
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-426799.9666.532368
HSA-MIR-548AT-5P99.9670.832666
HSA-MIR-96-5P99.9572.802140
HSA-MIR-185-3P99.9567.011743

Literature-anchored findings (GeneRIF, showing 4)

  • This study determined the first crystal structures of the cyclic nucleotide-binding homology (CNBH) domain domains of CNNM2 and CNNM3 at 2.6 and 1.9 A resolutions. (PMID:30341174)
  • A FRET-based screening method to detect potential inhibitors of the binding of CNNM3 to PRL2. (PMID:32733084)
  • CNN3 in glioma: The prognostic factor and a potential immunotherapeutic target. (PMID:34797350)
  • CNNM proteins selectively bind to the TRPM7 channel to stimulate divalent cation entry into cells. (PMID:34928937)

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
ENSDARG00000099568
mus_musculusCnnm3ENSMUSG00000001138
rattus_norvegicusCnnm3ENSRNOG00000016032
drosophila_melanogasteruexFBGN0262124
caenorhabditis_elegansWBGENE00011260
caenorhabditis_elegansWBGENE00016343
caenorhabditis_elegansWBGENE00016879

Paralogs (3): CNNM1 (ENSG00000119946), CNNM2 (ENSG00000148842), CNNM4 (ENSG00000158158)

Protein

Protein identifiers

Metal transporter CNNM3Q8NE01 (reviewed: Q8NE01)

Alternative names: Ancient conserved domain-containing protein 3, Cyclin-M3

All UniProt accessions (1): Q8NE01

UniProt curated annotations — full annotation on UniProt →

Function. Probable metal transporter.

Subcellular location. Cell membrane.

Tissue specificity. Widely expressed. Expressed at higher level in heart and spleen.

Miscellaneous. Shares weak sequence similarity with the cyclin family, hence its name. However, it has no cyclin-like function in vivo.

Similarity. Belongs to the ACDP family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8NE01-11yes
Q8NE01-22
Q8NE01-33

RefSeq proteins (2): NP_060093, NP_951060 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000644CBS_domDomain
IPR002550CNNMDomain
IPR044751Ion_transp-like_CBSDomain
IPR045095ACDPFamily
IPR046342CBS_dom_sfHomologous_superfamily

Pfam: PF00571, PF25562

UniProt features (57 total): strand 16, helix 14, sequence conflict 7, turn 5, transmembrane region 4, domain 3, modified residue 2, splice variant 2, chain 1, glycosylation site 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

7 structures.

PDBMethodResolution (Å)
6DFDX-RAY DIFFRACTION1.9
6WURX-RAY DIFFRACTION2.88
5K23X-RAY DIFFRACTION2.96
5K22X-RAY DIFFRACTION3
5K25X-RAY DIFFRACTION3.05
5TSRX-RAY DIFFRACTION3.19
6MN6X-RAY DIFFRACTION3.36

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NE01-F167.630.19

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 661, 700

Glycosylation sites (1): 73

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 116 (showing top): FISCHER_G1_S_CELL_CYCLE, FOXO1_01, WANG_RESPONSE_TO_BEXAROTENE_UP, FREAC3_01, ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN, GOBP_MONOATOMIC_ION_HOMEOSTASIS, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_HOMEOSTATIC_PROCESS, GOBP_CHEMICAL_HOMEOSTASIS, chr2q11, GOMF_TRANSPORTER_ACTIVITY, FOXO3_01, GOBP_MAGNESIUM_ION_HOMEOSTASIS, KASLER_HDAC7_TARGETS_1_UP, FEVR_CTNNB1_TARGETS_DN

GO Biological Process (3): monoatomic ion transport (GO:0006811), magnesium ion homeostasis (GO:0010960), transmembrane transport (GO:0055085)

GO Molecular Function (2): transmembrane transporter activity (GO:0022857), protein binding (GO:0005515)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport2
monoatomic cation homeostasis1
inorganic ion homeostasis1
cellular process1
transporter activity1
transmembrane transport1
binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

954 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CNNM3PTP4A2Q12974962
CNNM3H7C2H4H7C2H4853
CNNM3P0DN79P0DN79834
CNNM3SLC41A1Q8IVJ1672
CNNM3NIPAL3Q6P499605
CNNM3NIPAL2Q9H841595
CNNM3NIPAL1Q6NVV3593
CNNM3TRPM6Q9BX84593
CNNM3NIPAL4Q0D2K0583
CNNM3FAHD2BQ6P2I3571
CNNM3NIPA2Q8N8Q9553
CNNM3FAM178BQ8IXR5541
CNNM3SLC41A3Q96GZ6515
CNNM3TRPM7Q96QT4502
CNNM3SLC41A2Q96JW4498

IntAct

317 interactions, top by confidence:

ABTypeScore
CNNM3FHL3psi-mi:“MI:0915”(physical association)0.780
FHL3CNNM3psi-mi:“MI:0915”(physical association)0.780
CNNM3MDFIpsi-mi:“MI:0915”(physical association)0.760
CNNM3KRTAP5-9psi-mi:“MI:0915”(physical association)0.720
KRTAP10-8CNNM3psi-mi:“MI:0915”(physical association)0.720
CNNM3KRTAP10-9psi-mi:“MI:0915”(physical association)0.720
KRTAP5-9CNNM3psi-mi:“MI:0915”(physical association)0.720
KRTAP10-9CNNM3psi-mi:“MI:0915”(physical association)0.720
PTP4A2PTP4A3psi-mi:“MI:0914”(association)0.640
CANXPGRMC1psi-mi:“MI:0914”(association)0.570
CCNDBP1CNNM3psi-mi:“MI:0915”(physical association)0.560
KRTAP2-3CNNM3psi-mi:“MI:0915”(physical association)0.560
KRTAP10-5CNNM3psi-mi:“MI:0915”(physical association)0.560
CNNM3CBY2psi-mi:“MI:0915”(physical association)0.560
PNMA1CNNM3psi-mi:“MI:0915”(physical association)0.560
LZTS2CNNM3psi-mi:“MI:0915”(physical association)0.560
CNNM3CCNDBP1psi-mi:“MI:0915”(physical association)0.560

BioGRID (278): CNNM3 (Two-hybrid), CNNM3 (Two-hybrid), CNNM3 (Two-hybrid), CNNM3 (Two-hybrid), USHBP1 (Two-hybrid), KRTAP3-2 (Two-hybrid), LZTS2 (Two-hybrid), KRTAP2-4 (Two-hybrid), SPERT (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), CNNM3 (Affinity Capture-MS), CNNM3 (Two-hybrid), KRTAP4-12 (Two-hybrid)

ESM2 similar proteins: A4FV98, A5PK51, A6NDG6, E1BE10, O00587, O35595, O95294, P60487, Q12788, Q17QS4, Q1JPJ0, Q2T9S4, Q2TBI8, Q32NY4, Q3T063, Q3ZBF9, Q501J2, Q5E9V4, Q5F4B1, Q5IS64, Q5SUV1, Q5T9C9, Q6AYG0, Q6AYR8, Q6XQN1, Q6XQN6, Q6ZMM2, Q80US4, Q8BNV1, Q8BZG5, Q8CC86, Q8IZ69, Q8N9H8, Q8NE01, Q8R2H9, Q8TCT1, Q8VCA8, Q8VD52, Q969S8, Q96AZ1

Diamond homologs: A0A0B7P9G0, A0A131MCZ8, A0JPA0, A3QM97, A8EZU0, A8F2M1, A8GPR9, A8GTI4, A8GUH1, O05961, P0C588, Q0GA42, Q12296, Q1RGX2, Q32NY4, Q3TWN3, Q4UK99, Q4V3C7, Q54318, Q57368, Q5U2P1, Q67XQ0, Q68W10, Q69ZF7, Q6P4Q7, Q8NE01, Q8RY60, Q8VZI2, Q92GI2, Q9GYL2, Q9H8M5, Q9LTD8, Q9NRU3, Q9USJ3, Q9ZQR4, Q9ZVS8, Q9CM13, Q9LK65, O05241, O07585

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 80 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization2123.4×6e-22

GO biological processes:

GO termPartnersFoldFDR
regulation of alternative mRNA splicing, via spliceosome521.8×9e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

153 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance138
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1385 predictions. Top by Δscore:

VariantEffectΔscore
2:96817498:GCGAG:Gdonor_gain1.0000
2:96825053:CACA:Cacceptor_loss1.0000
2:96825054:ACAG:Aacceptor_gain1.0000
2:96825055:CA:Cacceptor_loss1.0000
2:96825056:A:AGacceptor_gain1.0000
2:96825056:AG:Aacceptor_gain1.0000
2:96825056:AGG:Aacceptor_gain1.0000
2:96825057:G:Aacceptor_loss1.0000
2:96825057:G:GAacceptor_gain1.0000
2:96825057:GG:Gacceptor_gain1.0000
2:96825057:GGG:Gacceptor_gain1.0000
2:96825057:GGGA:Gacceptor_gain1.0000
2:96825057:GGGAA:Gacceptor_gain1.0000
2:96825197:CTACC:Cdonor_gain1.0000
2:96825198:TACC:Tdonor_gain1.0000
2:96825199:ACC:Adonor_gain1.0000
2:96825200:CC:Cdonor_gain1.0000
2:96825202:G:GGdonor_gain1.0000
2:96826826:A:AGacceptor_gain1.0000
2:96826827:T:Gacceptor_gain1.0000
2:96826830:TAG:Tacceptor_loss1.0000
2:96826831:A:AGacceptor_gain1.0000
2:96826831:AG:Aacceptor_gain1.0000
2:96826832:G:Aacceptor_loss1.0000
2:96826832:G:GGacceptor_gain1.0000
2:96826832:GG:Gacceptor_gain1.0000
2:96826832:GGA:Gacceptor_gain1.0000
2:96826832:GGAGA:Gacceptor_gain1.0000
2:96826931:G:GGdonor_gain1.0000
2:96826979:CGAG:Cdonor_loss1.0000

AlphaMissense

4467 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:96817455:T:AV393D0.999
2:96817457:T:CF394L0.999
2:96817459:C:AF394L0.999
2:96817459:C:GF394L0.999
2:96817494:T:CF406S0.999
2:96825072:G:CA414P0.999
2:96825073:C:AA414D0.999
2:96825136:T:AV435D0.999
2:96817482:T:AV402D0.998
2:96825079:T:AV416E0.998
2:96825129:G:CG433R0.998
2:96827856:T:GY549D0.998
2:96827890:T:CL560P0.998
2:96828106:T:AV566D0.998
2:96828138:T:CF577L0.998
2:96828140:T:AF577L0.998
2:96828140:T:GF577L0.998
2:96828153:T:CF582L0.998
2:96828155:C:AF582L0.998
2:96828155:C:GF582L0.998
2:96828166:G:AG586E0.998
2:96829011:T:GY646D0.998
2:96817320:G:CR348P0.997
2:96817326:C:AP350Q0.997
2:96817457:T:AF394I0.997
2:96817485:T:CL403P0.997
2:96817493:T:CF406L0.997
2:96817495:C:AF406L0.997
2:96817495:C:GF406L0.997
2:96825070:T:CL413P0.997

dbSNP variants (sampled 300 via entrez): RS1000127740 (2:96815099 T>C,G), RS1000182020 (2:96815421 A>G), RS1000354178 (2:96821384 A>G), RS1000403109 (2:96827091 C>A,G,T), RS1000640626 (2:96822717 C>A,T), RS1000641398 (2:96829921 T>G), RS1000680235 (2:96818490 A>G,T), RS1001044115 (2:96835061 C>A), RS1001078352 (2:96817877 GA>G), RS1001140620 (2:96828367 C>T), RS1001240015 (2:96822106 G>A), RS1001296341 (2:96833230 G>A,C), RS1001412002 (2:96833413 G>A,C,T), RS1001469297 (2:96817721 G>C), RS1001471407 (2:96829679 A>G)

Disease associations

OMIM: gene MIM:607804 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST000824_20Erectile dysfunction and prostate cancer treatment6.000000e-06
GCST008103_13Bipolar disorder4.000000e-09
GCST008362_203Birth weight3.000000e-09
GCST008363_28Offspring birth weight5.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004344birth weight
EFO:0005939parental genotype effect measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

31 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression, increases methylation2
Cyclosporinedecreases expression2
Aflatoxin B1decreases expression, increases methylation2
FR900359affects phosphorylation1
triphenyl phosphateaffects expression1
sodium arseniteincreases abundance, increases expression1
perfluorooctanoic aciddecreases expression1
benzo(e)pyreneincreases methylation1
coumarinincreases phosphorylation1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
(+)-JQ1 compoundincreases expression1
Temozolomideincreases expression1
Acetaminophenaffects response to substance1
Air Pollutantsincreases abundance, affects expression1
Arsenicincreases abundance, increases expression1
Benzo(a)pyreneaffects methylation1
Caffeineaffects phosphorylation1
Diazinonincreases methylation1
Hydralazineaffects cotreatment, increases expression1
Methapyrileneincreases methylation1
Ozoneaffects expression, increases abundance1
Selenomethionineaffects expression1
Smokedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1
tert-Butylhydroperoxidedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.